Cardiac Success
Ventricular Repair Device for Patients with Heart Failure
Company Overview
Snapshot
Founded in August 2017 by David Neustadter, Cardiac Success operates with 1–10 employees. The company has raised $6.82M across 3 funding rounds from 3 investors.
Business overview
Cardiac Success is developing the V-sling, a transcatheter ventricular repair device designed to improve the lives of patients experiencing deterioration from heart failure with reduced ejection fraction (HFrEF). The device's design is based on a successful surgical papillary muscle approximation procedure. The company operates in the Health Tech & Life Sciences sector, specifically focusing on medical devices and medical treatment, serving patients and healthcare providers.
Strategic signal
This investment signals continued investor confidence in the company's innovative V-sling device and its potential to address a significant unmet medical need in heart failure treatment, suggesting a positive trajectory for its R&D and market entry efforts.
Log in to access full profile ›Company Intelligence Q&A
- What is Cardiac Success's primary product?
- Cardiac Success is developing the V-sling, a transcatheter ventricular repair device designed to treat heart failure with reduced ejection fraction (HFrEF).
- When was Cardiac Success founded?
- Cardiac Success was founded in August 2017.
- Who is a co-founder of Cardiac Success?
- David Neustadter is a co-founder and CTO of Cardiac Success.